Stratos Wealth Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,940
| Closed | -$263K | – | 1509 |
|
|
2024
Q3 | $263K | Buy |
3,940
+291
| +8% | +$19.4K | ﹤0.01% | 1212 |
|
|
2024
Q2 | $433K | Sell |
3,649
-2,043
| -36% | -$243K | 0.01% | 957 |
|
|
2024
Q1 | $607K | Buy |
5,692
+547
| +11% | +$58.3K | 0.01% | 825 |
|
|
2023
Q4 | $512K | Sell |
5,145
-1,126
| -18% | -$112K | 0.01% | 872 |
|
|
2023
Q3 | $648K | Sell |
6,271
-1,689
| -21% | -$174K | 0.01% | 724 |
|
|
2023
Q2 | $967K | Buy |
7,960
+1,811
| +29% | +$220K | 0.02% | 542 |
|
|
2023
Q1 | $944K | Sell |
6,149
-942
| -13% | -$145K | 0.03% | 501 |
|
|
2022
Q4 | $1.27M | Buy |
7,091
+61
| +0.9% | +$11K | 0.03% | 445 |
|
|
2022
Q3 | $831K | Sell |
7,030
-2,226
| -24% | -$263K | 0.02% | 538 |
|
|
2022
Q2 | $1.32M | Sell |
9,256
-516
| -5% | -$73.7K | 0.03% | 424 |
|
|
2022
Q1 | $1.68M | Buy |
9,772
+1,056
| +12% | +$182K | 0.04% | 408 |
|
|
2021
Q4 | $2.21M | Sell |
8,716
-6,557
| -43% | -$1.67M | 0.05% | 334 |
|
|
2021
Q3 | $5.88M | Sell |
15,273
-2,238
| -13% | -$861K | 0.15% | 151 |
|
|
2021
Q2 | $4.12M | Buy |
17,511
+253
| +1% | +$59.5K | 0.1% | 209 |
|
|
2021
Q1 | $2.26M | Buy |
17,258
+41
| +0.2% | +$5.37K | 0.06% | 269 |
|
|
2020
Q4 | $1.8M | Buy |
17,217
+6,078
| +55% | +$635K | 0.05% | 291 |
|
|
2020
Q3 | $788K | Buy |
11,139
+3,229
| +41% | +$228K | 0.03% | 471 |
|
|
2020
Q2 | $508K | Buy |
+7,910
| New | +$508K | 0.02% | 585 |
|